Study Links Pregnancy-Specific Genes to Poorer Lung Cancer Outcomes in Women
Recent study uncovers how lung cancer exploits genes related to fetal growth to evade immune system, leading to poorer outcomes in women. Calidi Biotherapeutics Inc. and other companies are exploring immune therapies based on this discovery.
This news sheds light on how lung cancer manipulates genes to escape immune surveillance, potentially paving the way for innovative immune therapies. Understanding these mechanisms can lead to improved treatment strategies and outcomes for patients battling cancer.
